Ginkgo Bioworks and Apheris formed a strategic partnership to launch the Antibody Developability Consortium.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ginkgo Bioworks and Apheris formed a strategic partnership to launch the Antibody Developability Consortium.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ginkgo Bioworks
American biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireGinkgo Datapoints and Apheris Launch Antibody Developability Consortium Ginkgo to Run AbDev AI Competition BOSTON, September 04, 2025--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced a s